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Summary The origin and nature of osteoclast-like multinucleated giant cells (OMGCs), in extraskeletal
neoplasms, is uncertain. The ultrastructure, antigenic phenotype and function of OMGCs in a breast
carcinoma were studied in order to clarify the relationship between OMGCs, osteoclasts and other cells of the
mononuclear phagocyte system (MPS). OMGCs resorbed cortical bone in a manner similar to osteoclasts.
However, unlike osteoclasts, OMGCs did not possess a ruffled border or clear zone, and expressed HLA-DR
and Fc receptors and CD14, CD16, CD18 and CD11 (pl50,95) antigens. In addition, OMGCs failed to
respond morphologically to calcitonin and were directly stimulated by parathyroid hormone (PTH) to
increase bone resorption. These findings suggest that OMGCs are a specific type of macrophage polykaryon
distinct from both osteoclasts and other types of inflammatory polykaryon. Occasional smaller (20-25pm)
macrophage-like cells were also associated with resorption pits. Bone resorption by OMGCs isolated from the
breast indicates that a cell of the MPS can be transplanted to a new tissue location and perform a highly
specialised function appropriate to an MPS cell of that tissue (i.e. the osteoclast). PTH stimulation of bone
resorption by OMGCs suggests that PTH or a PTH-like protein, may be involved in the bone resorption and
consequent hypercalcaemia associated with metastatic breast cancer.
Osteoclast-like multinucleated giant cells are rarely found in
otherwise typical infiltrating breast cancers (Fry, 1927;
Agnantis & Rosen, 1978; Factor et al., 1977; Holland & van
Haelst, 1984; Nielsen & Kiaer, 1985; Tavassoli & Norris,
1986) and tumours in other extraskeletal sites (Andreev et
al., 1964; Dorney, 1967; Nishiyama et al., 1972; Eshun-
Wilson, 1973; Balogh et al., 1985; Berendt et al., 1985). The
origin and nature of these cells and their relationship to
osteoclasts and macrophage polykaryons is unknown. They
are present in the tumour stroma and are generally thought
to represent part of the host reponse to the tumour rather
than a type of tumour cell. However, their precise function
and pathological significance is yet to be determined.
In this study, we have examined the ultrastructure and
antigenic phenotype of osteoclast-like stromal multinucleate
giant cells (OMGCs) in a case of breast carcinoma. We have
employed a wide range of monoclonal antibodies of defined
specificity in order to clarify the relationship between
OMGCs, tumour cells, the osteoclast and other cells of the
mononuclear phagocyte system. In addition, we have func-
tionally assessed whether OMGCs behaved like osteoclasts
by observing their response to calcitonin and their ability to
resorb bone in the presence and absence of known hormonal
factors influencing bone resorption. Our findings have impli-
cations for macrophage biology and tumour associated
osteolysis.
Materials and methods
Bovine parathyroid hormone (PTH) (2,500 Umg-1) was
provided by Dr J. Zanelli (National Institute for Biological
Standards, London, UK) and dissolved (230 IUml-1) in 1 ml
0.001% acetic acid in distilled water containing 1 mgml- I of
bovine serum albumin (Sigma, UK) (BSA). Salmon calcito-
nin (CT) was donated by Armour Pharmaceuticals, East-
bourne, UK (4,450IU.mg-1) and dissolved (I mgml-1) in
0.05% NaCl and 0.2% sodium acetate in distilled water
containing 1 mgml-1 of BSA. Prostaglandin E2(Sigma)
(PGE2) was dissolved (10-2 M) in alcohol. 1,25-Dihydroxy
vitamin D3 (1,25-(OH)2D3) was donated by Roche products
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(Welwyn Garden City, UK) and dissolved in alcohol. Tissue
culture medium used throughout was Eagles Minimal Essen-
tial Medium (Flow, UK), supplemented with benzyl penicil-
lin 100 IUml-1 (Glaxo, UK) and streptomycin 100pgml-1
(Glaxo) (MEM); this was used alone for cell isolation and
supplemented with 10% heat inactivated FCS (Gibco, UK)
(MEM/FCS) for subsequent incubations.
Blocks of cortical bone were obtained at necropsy from
the femoral midshaft of patients who had died without
evidence of bone disease. These were cleaned of adherent
soft tissues then cut longitudinally into bone slices
(5 x 3 x 0.3 mm approx) with a low-speed bone saw using a
diamond wheel (Buehler Isomet, IL). The bone slices were
ultrasonicated for 15min in sterile distilled water, washed in
acetone and ethanol then stored dry at room temperature.
Anorganic bone slices were prepared by placing bone slices
in 5ml of hot (55°C) 1,2 ethanediamine (Hydrazine) (East-
man, UK). The solution was changed after one hour and the
bone slices then kept in hot hydrazine overnight (Termine et
al., 1973). The bone slices were washed several times in
alcohol then left overnight in alcohol. They were then
washed in distilled water, dried and transferred to a sterile
petri dish and kept at room temperature until used.
Patient details
A 45-year-old woman had noted a lump in the upper outer
quadrant of her left breast which had recently increased in
size. She had no family history of breast carcinoma and had
been on oral contraceptive therapy for the preceding twelve
months. Ten years previously she had bilateral silicone
breast implants inserted and two years previously had under-
gone a termination of pregnancy for social reasons. On
examination, there was a 2cm hard, mobile lump in the
upper, outer quadrant of the left breast. Fine needle aspi-
ration cytology of the lesion showed that it was a breast
carcinoma with numerous OMGCs. She underwent a left
segmental excision of the lesion with preservation of the
silicone implant. Axillary nodes were sampled and a biopsy
of a lump in the right breast was also taken; the latter was
considered benign, clinically and cytologically. Investigations
showed normal values for serum, calcium, phosphate and
alkaline phosphatase. A bone scan revealed a hot spot in the
left femur. No lesion was seen on bone X-ray and the
radiological opinion was that this was most likely a benign
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lesion and unlikely to represent a metastasis. The patient
made a good postoperative recovery and was treated with
radiotherapy. She has been clear of any signs of recurrence
for 12 months.
Cytological, histological and transmission EM techniques
Fine needle aspiration cytology was performed using a 10ml
syringe with a 22 gauge needle. The aspirated material was
mounted on glass slides, air-dried for May Grunwald
Giemsa staining and fixed in 95% ethanol for Papanicolau
and immunohistochemical staining (with monoclonal anti-
bodies, EBM-11, PD7/26 and CAM 5.2).
The specimen of breast containing the carcinoma, which
had previously been diagnosed on fine needle aspiration
cytology, was received fresh. Sufficient blocks were taken for
diagnostic histology; these were fixed in formalin, routinely
processed and stained with Haematoxylin and Eosin (H &
E). Samples of the tumour were also snap frozen in liquid
nitrogen and then stored at -20°C for cryostat sectioning.
Several antigenic determinants were located in cryostat
sections of the tumour after the application of the mono-
clonal antibodies listed in Table I. Immunohistochemistry
was performed by immunoperoxidase or alkaline phospha-
tase anti-alkaline phosphatase (APAAP) procedures as pre-
viously described (Gatter et al., 1984). Cryostat sections were
also stained for tartrate-resistant acid phosphatase using the
method described by Evans et al. (1979). Tissue for trans-
mission electron microscopy was fixed in 4% glutaraldehyde
for 6h, dehydrated in graded alcohols then embedded in
epoxy resin (EMix). Thin sections were stained with uranyl
acetate and lead citrate and examined in a Jeol 100 CX
electron microscope.
Preparation of isolated giant cells
The remainder of the tumour was placed in MEM and
utilised immediately for tissue culture. The tumour was
divided into equal portions and placed in a 35mm tissue
culture dish (Sterilin) containing 2ml of MEM/FCS. The
tumour was finely curetted using a scalpel blade and the
fragments vigorously agitated using a smooth-ended glass
pipette. Larger fragments were allowed to sediment for one
minute and 1 ml of the suspension then added to the various
tissue culture dishes as detailed below. Phase contrast exam-
ination of these suspensions revealed large numbers of
multinucleated cells interspersed amongst abundant mono-
nuclear cells.
Response to calcitonin
Following curettage, the tumour cell suspension was added
to the wells of a 16mm diameter Costar plate containing a
15mm glass coverslip; these were incubated for 20min at
37°C in 5% CO2. The coverslips were then removed from
these wells and washed vigorously to remove non-adherent
cells. One of a pair of coverslips was then placed in a well
containing CT (1 ngml-1), the other in control tissue culture
medium. The cells were then incubated for 5min, 10min,
30min, 1 h and 2h before formalin fixation for staining
(Giemsa). The effectiveness of the CT used in this experi-
ment to inhibit osteoclast motility and induce the character-
istic change in osteoclast morphology was confirmed by
adding the same CT solution to neonatal rodent osteoclasts
which had been isolated in a similar manner as previously
described (Chambers & Magnus, 1982).
Incubation of giant cells on bone slices
Following curettage, the tumour cell suspension was added
to the wells (16mm diameter) of a tissue culture plate
(Costar, UK) containing four or five bone slices (see below)
or 15 mm glass coverslips. The cell suspension was incubated
on these for 20min at 37°C, then the bone slices and the
coverslips were removed, washed vigorously in MEM and
placed in fresh 16mm diameter wells. For the bone slices,
these contained PTH (1 IUm-1), PGE2 (10-5 M), CT
(1 nhml-1), 1.25 (OH)2 D3 (10-8 M) or appropriate vehicle
controls in 1 ml of MEM/FCS. These were incubated for
periods of 24h, 3 days and 7 days. The 24h and 3 day
cultures contained five bone slices, including one anorganic
bone slice; 7 day cultures contained four bone slices. Three
bone slices, including one anorganic bone slice derived from
24h and 3 day cultures and two bone slices from the 7 day
cultures, were fixed in 4% glutaraldehyde in 0.2M cacodylate
buffer for 2h. Two bone slices were placed in Triton X-100
(0.1% in distilled water) for 6h before glutaraldehyde fixa-
tion. Triton treatment removes the cells from the bone
surface and enables the underlying substrate to be examined
and the number of resorption pits to be accurately counted.
The specimens were dehydrated through a graded ethanol
series and critical point dried from CO2.
Specimens were coated with gold and examined in a
Philips SEM 505 scanning electron microscope. The number
of giant cells on the bone slices and the number of resorp-
tion pits on the corresponding Triton-treated bone slices
which had shared the same well were counted in cultures
incubated for 24h and 3 days. The surface area of each
resorption pit was calculated by tracing the outline of the pit
on to a digitising tablet linked to a Kontron MOP AMO3
image analyser.
The coverslips, which contained curetted cells from the
tumour, were also incubated in MEM/FCS for 24h, 3 days
and 7 days in order to assess survival of the giant cells
during incubation and, after fixation in cold acetone, to
examine the nature of the cells present on the coverslips by
immunohistochemistry with monoclonal antibodies PD7/26,
EBM/ll and CAM 5.2.
Results
Cytopathology/histopathology
The appearance of the cytological smears showed clusters of
carcinoma cells and numerous dissociated malignant cells
with cytological features similar to the cells in the clumps. In
addition, a number of multinucleated cells and occasional
morphologically similar mononuclear cells were also present
singly and associated with the tumour cell clumps (Figure 1).
The giant cells had large nuclei with prominent nucleoli and
a rather basophilic cytoplasm compared to the surrounding
tumour cells. The tumour cells were present in large numbers
and were hyperchromatic with anisokaryosis and increased
nuclear cytoplasmic ratio.
Grossly, the tumour was a brown 2cm diameter well-
circumscribed tumour which did not extend to the margins
Figure 1 Cytological smear of the tumour showing a clump of
tumour cells with a single multinucleated giant cell (arrowed)
(Giemsa x 136).
4*4'STROMAL OSTEOCLAST-LIKE GIANT CELLS 493
of excision. The silicone implant was not removed and by
light microscopy no silicone was found in the tumour itself.
The tumour was an invasive cribriform carcinoma of the
breast with a pattern of cribriform islands of well-
differentiated tumour cells showing luminal differentiation
around cyst-like spaces. Throughout the tumour there were
numerous multinucleated giant cells resembling osteoclasts;
these cells were often in close apposition to the tumour cell
islands (Figure 2). No tumour necrosis was present but, as is
characteristic of this type of breast cancer, there was abun-
dant haemosiderin. No metastatic tumour was found in the
axillary lymph nodes.
Immunohistochemistry
The results of the immunohistochemical staining of cryostat
sections of this case of breast carcinoma with stromal
OMGCs are shown in Table I. The reaction of tumour cells,
OMGCs and mononuclear stromal cells is noted. OMGCs,
unlike tumour cells, were negative for all epithelial markers
(Figure 3a) but positive for leucocyte common antigen
(LCA) (Figure 3b). OMGCs also stained with numerous
other monoclonal antibodies which react with osteoclasts
and cells of the mononuclear phagocyte system, including
anti-CD13 antibodies and several antibodies which react
with macrophages in a wide variety of tissues, including
EBM/l1 (Kelly et al., 1988) and Y-1/82a (Hogg & Horton,
1987) (Figure 3c). All of these antibodies also strongly
Figure 2 Representative field of the tumour showing well differ-
entiated tumour cells islands and ducts with numerous associated
OMGCs, some of which are arrowed (Haematoxylin and
Eosin x 120).
Table I Monoclonal antibodies used in the present study and results of staining
Antigen specificity
Epithelial membrane antigen
Cytokeratin intermediate filaments
Cytokeratin intermediate filaments
Cytokeratin intermediate filaments
Leucocyte common antigen
Leucocyte common antigen
Leucocyte common antigen
Leucocyte common antigen
Fc receptor
Fc receptor
CR1 (C3b receptor)
CR1 (C3b receptor)
CR1 (C3b receptor)
CR1 (C3b receptor)
CD1lc (p450, 95)
CD11c (plI50, 95)
Cdllc (p150, 95)
Class II
Class II
Class II
CDl (CR3)
CD11 (CR3)
CD13
CD13
CD13
CD14
CD14
CD14
CD14
CD15
CD15
CD15
CD15
CD16
CD16
CD16
CD16
CD18
CD18
CD18
Platelet glycoprotein Illa (gp Illa)
gpIIIa
Monocyte/macrophage
Monocyte/macrophage
Source: reference
Cordell et al. (1985)
Viac et al. (1981)
Makin et al. (1984)
Dakopatts a/s
Warnke et al. (1983)
Warnke et al. (1983)
Trowbridgea
Horjesia
Faracea
Pilkingtona
Masona
Hogga
Boucherxa
Coucherxa
Johnsona
Radzuna
MacDonald et al. (1986)
Bodmera
Werneta
Naiem et al. (1981)
Hogga
Todda
Griffina
Winchestera
Sagawaa
Zolaa
Winchestera
Beverleya
Griffina
Riebera
Ponceleta
Bernsteena
Herrmanna
von den Bornea
Yokoyamaa
Garridoa
Kurrlea
Beattya
McMichaela
McMichaela
Mason (Tetteroo et al.,
1983)
Masona
Masona
McGhee (Kelly et al.,
1988)
Reactivity of
Reactivity stromal mono Reactivity of
ofgiant cells nuclear cells tumour cells
_ - ~++
_ - ~++
_ - ~+ +
+ + =strong staining; + =weak staining. aReference Hogg & Horton (1987).
Antibody
E29
KL1
CAM5.2
LP34
PD7/26
2Bll
T29/33
MEM28
2E1
CIKM5
T05
Ell
JBll
J3D3
BU15
Ki-MI
KB90
DA2
TU2
CR3/43
44
MO1
My7
MoV48
Mc52
FMC32
M051
UCHM1
My4
M-G54
FP2-9-8-A3
IGIO
M217
CLB/Fcgran I
MG38
6RM1
BW209/2
60.3
MHM23
MHM24
C17
Y2/51
Yl/82a
EBM-11
++
++
++
++
+
+
+
+
+
+
+
+
++
++
++
++
++
++
+
+
++
++
++
++
++
++
++
+
+
+
++
++
++
++
++
+
+
+
+
++
++
+
+
+
+
+
+
+
+
+
++ +
++ +
++ ++
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a
b
b
Figure 3 Indirect immunoperoxidase staining of the tumour
with monoclonal antibody. (a) E29 (anti-epithelial membrane
antigen) showing staining of tumour cells but no reaction of
OMGCs (x 152). (b) PD7/26 (anti-LCA) showing membrane
staining of OMGCs (x 190). (c) EBM/11 (anti-macrophage)
showing cytoplasmic staining of OMGCs (x 190).
stained numerous mononuclear stromal cells (presumptive
macrophages). OMGCs, like osteoclasts, also reacted for the
CD9 and glycoprotein Illa antigens expressed on platelets.
OMGCs, however, did show differences in their antigenic
phenotype from human osteoclasts. These include positive
reactions for HLA-DR, Fc receptor, CD14, CD16, CD18
and CDllc (p150,95) antigens which are not detectable on
osteoclasts.
Ultrastructural findings
The giant cells had multiple nuclei with irregular outlines.
The nucleoplasm contained small amounts of peripherally
located dense heterochromatin plus large nucleoli (Figure
4a). The cytoplasm contained large amounts of rough endo-
plasmic reticulin (rER). Both long and short strands of rER
were observed. Some of the short strands appeared dilated
and contained flocculent material (Figure 4b). Numerous
Figure 4 Ultrastructural features of OMGCs. (a) Low power
transmission electron micrograph showing two OMGCs (centre
and upper right). Note the close apposition of giant cell to the
tumour cells (lower right). Bar is 10tm. (b) Detail of the
cytoplasm of an OMGC showing the extensive Golgi bodies,
numerous mitochondria, strands of rough endoplasmic reticulum
and free ribosomes. Bar is 1Im. (c) Detail showing the close
apposition of the OMGC to the tumour cells. Note the amor-
phous organelle-free zone beneath the plasmalemma of the
OMGC. Bar is 1 pm.
free polyribosomes and mitochondria were distributed
throughout the cytoplasm. In addition, a number of active
appearing Golgi bodies were observed. Small vacuoles, someSTROMAL OSTEOCLAST-LIKE GIANT CELLS 495
of which had electron dense contents (lysosomes) were
present within the cytoplasm. Around the periphery of the
cell there was an organelle-free zone comprised of fine
filaments. The plasmalemma appeared relatively smooth but
in certain areas numerous finger-like and bulbous projection
were observed. These cells were present in the connective
tissue often in close apposition to the tumour cells but no
direct connection or localised changes in the tumour cells
was noted (Figure 4a, c).
OMGC morphology in cell cultures on coverslips and
response to calcitonin
No morphological difference between control and CT-treated
OMGCs was noted in short-term cultures (up to 2h). After
sedimentation and the brief settling time, the OMGCs
extended pseudopods and spread over the substrate. They
were clearly identifiable as multinuclear cells with several
cells possessing 20 or more nuclei, each with a prominent
nucleolus. OMGCs had an abundant, well spread pale
staining cytoplasm which in some cells appeared vacuolated.
The peripheral cytoplasmic outline was smooth and slightly
more densely stained. Unlike rat osteoclasts, which re-
sponded morphologically by retracting cytoplasmic pseudo-
pods within 3min of exposure to CT and maintaining this
response for the duration of the experiment, OMGCs re-
tained their well spread smooth cytoplasmic appearance in
short-term cultures (Figure 5). This morphological appear-
ance was unchanged in long-term cultures (up to 7 days) of
OMGCs on coverslips.
Mononuclear cells were present in both short-term and
long-term cultures. In short-term cultures, these included
obvious tumour cell clumps and scattered mononuclear cells
of round, spindle cell or stellate shape with thin, prominent
cytoplasmic pseudopods. Tumour cell clumps or cells with
abnormal nuclear morphology were not present in long-term
cultures although scattered mononuclear cells persisted. Both
OMGCs and the latter reacted for LCA and the macrophage
marker (EBM/ 11) and did not stain for cytokeratin interme-
diate filaments (CAM 5.2); this suggested that no epithelial
tumour cells remained in long-term (24h, 3 day and 7 day)
cultures.
OMGCs in cell cultures on bone slices
By SEM, OMGCs were easily distinguished from scattered
mononuclear cells by their large size (up to 100tim) and
distinctively complex morphology (Figure 6a and b); this
closely resembled that previously described for osteoclasts
(Chambers et al., 1984). They had many fine microvilli on
their free (upper) surface; these were usually concentrated
over the central area of the cell which was often raised into a
dome. OMGCs had lobuLdltcd and folded pseudopods over
Figure 5 OMGC incubated for 30min in medium containing
CT (1 ng ml -) showing pale cytoplasm with broad pseudopods
(x 235).
at least part of their periphery, the cell margin at other
points having fine filopodia or retraction fibres. The latter
were buried in the bone surface or amongst the collagen
fibres of a resorption cavity. No characteristic change in the
morphological appearance of OMGCs or other cells was
seen after OMGCs had been incubated in the presence of
CT, PTH, 1,25 (OH)2 D3 or PGE2 on SEM. The number of
OMGCs present on each bone slice declined over the period
of incubation in long-term cultures (Table II).
Bone resorption by OMGCs
In all long-term cell cultures, the bone showed characteristic
resorption pits in proximity to OMGCs. These closely
resembled osteoclastic resorption pits, being sharply defined
with coarsely fibrillar excavated bases. Frequently such pits
were partly covered by an OMGC, the fine retraction fibres
of the OMGC interdigitating with the mineralised collagen
fibrils of the cavity base (Figure 6a and b). OMGCs
produced resorption cavities of circular or serpiginous out-
lines and compound excavations which were combinations of
the above types. In addition, poorly defined areas of discern-
ible but unmeasurable roughening of the bone surface were
also seen particularly around defined resorption pits.
OMGCs were occasionally associated with more than one
resorption pit separated by an intervening tract of undis-
turbed bone (Figure 6a). This appearance suggested that a
single OMGC had produced these resorption pits and that
bone resorption had been intermittent and not continuous as
in the larger serpiginous or compound excavations. OMGCs
also appeared to be capable of resorbing bone without the
aid of other cells as resorption pits were often formed by
OMGCs with no other cells in the vicinity, particularly in
24h cultures (Figure 6a and b). OMGCs also resorbed
anorganic bone in 24h and 3 day cultures, indicating that
they are capable of resorbing the mineral component of bone
alone. The number of resorption pits on these anorganic
bone slices corresponded closely with the number on
untreated bone slices. Occasional smaller cells (less than
25 um) were also associated with resorption pits (Figure 6d),
suggesting that bone resorption was not only being carried
out by large multinucleate cells but also by smaller possibly
mononuclear cells.
Using two sets of paired bone slices, one of which was
Triton-treated to remove the cells covering the bone surface,
it was possible to determine changes in OMGC numbers and
resorption cavity formation over time (Table II). Clearly,
only a small minority of OMGCs were involved in bone
resorption in control and hormone-treated cultures. The
number of resorption pits did increase with the duration of
incubation of cell cultures, indicating that OMGCs were
capable of resorbing bone even after a prolonged period of
incubation; this was also suggested by the occasional obser-
vation of OMGCs partially overlying a resorption pit in 3
day and 7 day cultures.
Bone resorption by OMGCs was seen in both control and
hormone-treated cultures. CT had no effect on bone resorp-
tion by OMGCs; this was confirmed by measuring the
number and area of these pits which did not differ signifi-
cantly from control values. PGE2 and 1,25-(OH2) vit D3,
known stimulators of bone resorption in vivo, also did not
greatly influence the number or area of resorption pits
produced by OMGCs. However, administration of PTH to
OMGCs cultured on bone greatly increased the number of
resorption pits (up to 20-fold). This effect was due to the
hormone and not to differences in OMGC number seeded
on the bones. The difference between PTH-treated and
control or other hormone treated cultures was less marked at
3 days than 24h, suggesting that PTH exerted its maximum
influence on bone resorption in the first 24h. The depth and
surface area of the pits was not significantly influenced by
hormone treatment although the largest and deepest pits on
bone slices were present in PTH-treated cultures.496 N.A. ATHANASOU et al.
Figure 6 (a) OMGC overlying simple resorption pit. Note broad pseudopods and retraction fibres at cell margin and microvilli
over free surface (bar is 10pm). (b) OMGC overlying complex compound resorption pit (bar is 10pm). (c) Three simple resorption
pits of roughly similar dimensions with intervening undisturbed bone (Triton-treated bone slice; bar is 10,pm). (d) Serpiginous
resorption pit associated with a smaller cell of macrophage-like morphology (bar is 10pm).
Table II Mean number of giant cells and resorption pits per bone
slice with mean surface area of pits after 24h and 3 days incubation
on bone slices
Mean number Mean surface
Mean number of of resorption area of
giant cells per pits resorption pits
bone slice (± s.e.m.) (pm2 +s.e.m.)
24h
Control
PTH
1.25 (OH)2D3
PGE2
Calcitonin
3 days
Control
PTH
1.25 (OH)2D3
PGE2
54
58
62
74
50
28
26
32
35
2(±0.57)
19 (±6.12)a
1 (±0.33)
2 (±1.15)
1 (±0.57)
2.30 (+1.85)
25.67 (± 10.01)a
4.67 (±1.86)
3.0 (± 1.53)
558 (±219)
653 (± 76)
277 (+117)
393 (± 63)
421 (±127)
424 (±125)
560 (±78)
397 (±103)
283 (±48)
aP<0.05 compared with controls, Student's t test.
Discussion
The superficial histological resemblance between osteoclasts
and stromal giant cells found in several tumours in a number
of extraskeletal sites has led to these giant cells being termed
osteoclast-like. In this study, we have shown that a notable
additional property which OMGCs isolated from a breast
cancer share with osteoclasts is the ability to resorb bone;
indeed, to our knowledge, this is the first direct demon-
stration of bone resorption by a cell type which has not been
isolated from bone. In terms of morphological configuration
and area, the well-defined areas of bone resorption described
in association with OMGCs closely resemble those produced
by osteoclasts (Athanasou et al., 1984; Chambers et al.,
1984). The ability of OMGCs to resorb anorganic bone and
the occasional observation of isolated OMGCs in close
association with a resorption pit also suggests that OMGCs,
like osteoclasts, are capable of resorbing all the components
of bone. However, bone resorption by OMGCs significantly
differs from that of isolated osteoclasts in that it is directly
stimulated by PTH and not inhibited by calcitonin
(Chambers et al., 1984; McSheehy & Chambers, 1986a,b).
PTH stimulation of osteoclastic bone resorption has only
previously been seen when osteoclasts are incubated in the
presence of osteoblasts, and osteoclastic bone resorption is
also directly inhibited by calcitonin, a feature which is
reflected by the characteristic change in the shape of the cell
(Chambers & Magnus, 1982). This morphological response
to calcitonin was not exhibited by OMGCs isolated in short-
term cultures on coverslips.
Investigation of the antigenic phenotype of OMGCs also
showed some similarities and differences between OMGCs
and osteoclasts. OMGCs contained several antigenic determi-
nants known to be present on osteoclasts including LCA
(Athanasou et al., 1987; Brecher et al., 1986), CD13 and
other macrophage-associated antigens (Athanasou et al.,
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1988a), and platelet antigens glycoprotein lIla and CD9
(Athanasou et al., 1988b). However, OMGCs, unlike osteo-
clasts, were positive for HLA-DR, and Fc receptors as well
as CD14, CD16, CD18 and CDl1c (pl50,95) antigens. All
the above antigens are also expressed by mononuclear
phagocytes (Hogg & Horton, 1987), indicating that OMGCs
phenotypically can be regarded as a type of macrophage
polykaryon. It should be noted, however, that OMGCs did
not react with all the antimacrophage antibodies employed
in this study. In addition, OMGCs like osteoclasts were
positive for tartrate-resistant acid phosphatase. However,
this enzyme cannot be regarded as a specific marker for
osteoclasts (Andersson et al., 1986). The absence of reaction
for epithelial membrane antigen and cytokeratin staining is
further proof that the OMGCs are unlike the epithelial
tumour cells themselves.
Although osteoclasts and OMGCs were morphologically
and functionally indistinguishable by scanning electron
microscopy, OMGCs on transmission EM did not possess a
complex ruffled border with a surrounding clear zone, the
characteristic ultrastructural feature of the osteoclast
(Gothlin & Ericsson, 1976). In addition, the numerous
polyribosomes and cisternae of rER and the fine filament
bundles present in the sub-plasmalemmal zone are not
characteristic of osteoclasts and are more in keeping with the
ultrastructure of a macrophage polykaryon (Papadimitriou &
Walters, 1979).
The above findings suggest that OMGCs are a specific
type of macrophage polykaryon which is distinct from both
osteoclasts and other types of inflammatory polykaryons
such as foreign-body giant cells. Unlike other macrophage
polykaryons or macrophages themselves (Chambers &
Horton, 1984), OMGCs can resorb bone in a similar manner
to osteoclasts. Osteoclasts, like macrophage polykaryons
(Sutton & Weiss, 1966; Chambers, 1978) are formed by the
fusion of mononuclear precursors of bone marrow origin
(Marks, 1983; Chambers, 1985) and there is now consider-
able evidence to suggest that these mononuclear precursors
and osteoclasts themselves form part of the heterogeneous
population of cells in the mononuclear phagocyte system
(Mundy & Roodman, 1987). Accordingly, the cellular and
functional differences noted between OMGCs, osteoclasts
and macrophage polykaryons could be accounted for by the
concept of macrophage heterogeneity (Hopper et al., 1979).
Moreover, the fact that OMGCs isolated from the breast are
capable of resorbing bone indicates that a cell of the
mononuclear phagocyte system, when transplanted to a
different tissue, is capable of performing a highly specialised
function of a cell of the mononuclear phagocyte system
appropriate to that new tissue location. This suggests that
the origin and diversity of macrophage heterogeneity may be
determined by the particular local factors and tissue location
in which macrophages find themselves (Metcalf, 1984).
In vitro transformation of peripheral blood monocytes to
multinucleated giant cells is greatly increased in breast cancer
patients (Al Sumidiae, 1986) and in healthy women with a
strong family history of breast cancer (Morton et al., 1988).
It has been suggested that this type of giant cell formation is
induced by a virus present in monocytes of breast cancer
patients, and a retrovirus-like particle has recently been
observed ultrastructurally in monocytes and cultured giant
cells from patients with breast cancer (Al Sumidiae et al.,
1988). It is possible that a viral gene may also be present in
that subpopulation of mononuclear phagocytes which form
OMGCs in breast cancer with numerous OMGCs. Viral
genes could account for the distinct functional and antigenic
differences of these cells from tissue macrophages, inflamma-
tory polykarya and osteoclasts. However, it should be noted
that we did not observe virus-like particles in stromal
mononuclear cells or OMGCs such as those reported above.
Nor have they been reported in any of the many previous
ultrastructural studies of breast carcinoma with OMGCs
(Factor et al., 1977; Agnantis & Rosen, 1978; Rosen, 1979;
Holland & van Haelst, 1983; Sugano et al., 1983; Nielsen &
Kiaer, 1985; Tavassoli & Norris, 1986; McMahon et al.,
1986; Gupta et al., 1987).
The existence of an osteoclast-like cell which is directly
stimulated by PTH to resorb bone may provide a clue to the
cellular and molecular mechanisms of osteolysis associated
with malignant tumours. Osteoclasts are generally regarded
as the principal cell responsible for bone destruction in solid
tumours both in the presence and absence of metastases in
bone. No direct evidence of osteolysis by tumour cells has
been presented to date (Chambers, 1985). Our observation of
PTH stimulation of bone resorption by cells isolated from a
breast carcinoma supports the belief that PTH or a PTH-like
protein is important in the humoral hypercalcaemia of
malignancy (Mundy et al., 1984; Suva et al., 1987). It also
suggests a possible mechanism whereby solid tumours, such
as breast cancer, with bone metastases can effect bone
resorption. One of the known effects of PTH is to increase
the number of osteoclasts formed from pre-existing pre-
cursors (Wong, 1986). Production of a PTH-like protein by
breast cancer cells may be responsible for the accumulation
of OMGCs in the unusual primary breast cancer studied.
These OMGCs, although capable of bone resorption, have
no substrate to resorb in the breast. However, in the more
common situation of metastatic breast cancer in bone,
secretion of a PTH-like protein by cancer cells in bone
would lead to a similar accumulation of OMGCs and these
would then resorb the bony substrate in the vicinity of the
metastatic tumour cells.
The normal plasma levels of calcium and phosphate seen
in the case described are consistent with this concept. In
addition, the finding of smaller, possibly mononuclear, cells
in association with resorption pits suggests that mononuclear
phagocytes, which are commonly found in the inflammatory
infiltrate around malignant tumours, may be similarly
stimulated and capable of bone resorption.
This work has been funded by the Arthritis and Rheumatism
Council. We would like to thank Miss L. Watts for typing the
manuscript and Mr G. Richardson for processing the photographs.
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